Last edition
News about "Type 1 Diabetes (T1D)"
Novo Nordisk Brings World's First Once-Weekly Basal Insulin Awiqli to India
Novo Nordisk India has launched Awiqli, the world's first once-weekly basal insulin, offering adults with diabetes a more convenient treatment option with fewer injections.
Type 1 Diabetes (T1D) | 10/07/2026 | By News Bureau | 159
Syntax Bio and Mayo Clinic Partner on Type 1 Diabetes Cell Therapy
Syntax Bio and Mayo Clinic have partnered to accelerate the development of stem cell-derived pancreatic cell therapies for Type 1 Diabetes (T1D). The collaboration aims to advance regenerative medicine approaches that could restore insulin-producing cells.
Type 1 Diabetes (T1D) | 10/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy